|
ERAS
|
Erasca, Inc
|
US
|
NASDAQ
|
|
HOWL
|
Werewolf Therapeutics, Inc.
|
US
|
NASDAQ
|
|
NXTC
|
NextCure, Inc.
|
US
|
NASDAQ
|
|
RLAY
|
Relay Therapeutics, Inc.
|
US
|
NASDAQ
|
|
HMDCF
|
Hutchison China Ltd
|
US
|
OTC
|
|
0013
|
HUTCHMED China Ltd
|
HK
|
HK
|
|
6996
|
Antengene Corp Ltd
|
HK
|
HK
|
|
PHIL
|
Philogen SpA
|
IT
|
MI
|
|
ALTME
|
TME Pharma N.V.
|
FR
|
PA
|
|
CLDWW
|
Calidi Biotherapeutics, Inc.
|
US
|
US
|
|
GRTSQ
|
Gritstone bio, Inc.
|
US
|
US
|
|
08HH
|
SHANG.FOS.PHARM.GR.H YC 1
|
DE
|
F
|
|
2JQ
|
Gritstone Bio Inc
|
DE
|
F
|
|
3NK
|
ALPHAMAB ONCOLO.DL-000002
|
DE
|
F
|
|
722
|
ANTENGENE CORP. DL-0001
|
DE
|
F
|
|
H7T1
|
HUTCHMED (China) Limited
|
DE
|
F
|
|
H7T2
|
HUTCHMED (CHINA) LS-1
|
DE
|
F
|
|
08HH
|
Shanghai Fosun Pharmaceutical (Group) Co. Ltd
|
DE
|
STU
|